VivaGel® contains an innovative antimicrobial agent which is being applied to a range of sexual health products in development by Starpharma and its partners including:
The active ingredient of VivaGel® is the proprietary dendrimer, SPL7013, which has been shown in scientific studies to inhibit infection with viruses, including HIV and the genital herpes virus, and the growth of bacteria. Several clinical studies have successfully tested the safety and efficacy of VivaGel®.
VivaGel® has been shown to have efficacy for treatment of BV in a Phase 2 clinical study and a Phase 2 clinical study for the prevention of BV is currently in progress.
